Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5603.0077.75 (+1.41 %)

PREV CLOSE ( ) 5525.25

OPEN PRICE ( ) 5529.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1024

TODAY'S LOW / HIGH ( )5529.00 5656.35

52 WK LOW / HIGH ( )4382.25 6440

NSE5604.7574.95 (+1.36 %)

PREV CLOSE( ) 5529.80

OPEN PRICE ( ) 5571.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 5604.75 (10)

VOLUME 514688

TODAY'S LOW / HIGH( ) 5532.05 5665.00

52 WK LOW / HIGH ( )4380.8 6439.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-08 1973

Management Info

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

11Oct Alkem Laboratories rises on signing li
Alkem Laboratories is currently trading at Rs. 6213.50, up by 77.50 poin..

10Oct Alkem Laboratories signs licensing agr
Alkem Laboratories has entered into a licensing agreement with US-based..

19Sep Alkem Laboratories submits analyst mee
With reference to relevant provisions of SEBI (Listing Obligations and D..

17Sep Alkem Laboratories incorporates wholly
Alkem Laboratories has incorporated Wholly Owned Subsidiary (WOS) namely..

17Sep Alkem Laboratories informs about incor
Pursuant to Regulation 30 of the SEBI LODR Regulations, Alkem Laboratori..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	6975.8	17471.5
Gross Profit	7676.7	18810.3
Operating Profit	8478.3	22711.2
Net Sales	28719.7	97477.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Strides Pharma Scien (BSE) 1503.10 (7.94%)	M.Cap ( in Cr)13977.65
Concord Biotech (BSE) 1988.55 (4.74%)	M.Cap ( in Cr)20895.52
Divi's Lab (BSE) 5975.70 (1.35%)	M.Cap ( in Cr)158219.27
AMI Organics (BSE) 2096.15 (3.55%)	M.Cap ( in Cr)8568.81
Shilpa Medicare (BSE) 935.80 (6.35%)	M.Cap ( in Cr)9151.27

Shareholding Pattern

	PROMOTERS	55.66%
	NON-INSTITUTION	16.1%
	MUTUAL FUNDS/UTI	14.94%
	FI/BANKS/INSURANCE	3.18%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall...	5.54
LIC MF Healthcare F...	3.89
ICICI Pru Nifty Pha...	3.88
Nippon India Nifty ...	3.88
Tata India Pharma &...	3.77
Kotak Healthcare Fu...	3.62
ICICI Pru Large & M...	3.53

Risk Disclosures on Derivatives

Smart Quotes

ALKEM LABORATORIES LTD.